Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma

BACKGROUND: Alpha-l-fucosidase (AFU) not only detects hepatocellular carcinoma (HCC) early but also is used as a clinical prognostic indicator of several malignant tumors. However, no study has investigated the prognostic significance of AFU in a cohort of patients with esophageal squamous cell carc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Dis
Autors principals: Yu, Xiangyang, Zhang, Rusi, Yang, Tianzhen, Zhang, Mengqi, Xi, Kexing, Lin, Yongbin, Wen, Yingsheng, Wang, Gongming, Huang, Zirui, Zhang, Xuewen, Zhang, Lanjun
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790429/
https://ncbi.nlm.nih.gov/pubmed/31656672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.08.92
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars